Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | ATM | Q13315 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | PRKCA | P17252 | 3/20 | 0.53 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.53 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.53 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.53 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.49 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.49 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.49 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9932773 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL29377491 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL9932933 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL9933237 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL20767375 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL9934466 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL28846621 | 1.00 | CYP3A4 (0.66) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL3759681 | 0.98 | CYP3A4 (0.69) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL3759279 | 0.98 | CYP3A4 (0.69) | CYP3A4TSHRATMTDP1MAPT | |
| SCHEMBL3757067 | 0.98 | CYP3A4 (0.69) | CYP3A4TSHRATMTDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12503664-B2 | Ester based functional fluid | OLEON NV (BE) | 2025-12-23 | — | — | US | claimed |
| US-12329847-B2 | Cosmetic composition | TAIYO KAGAKU CO., LTD. (JP) | 2025-06-17 | — | — | US | claimed |
| US-20250170046-A1 | COSMETIC COMPOSITION | TAIYO KAGAKU CO., LTD. (JP) | 2025-05-29 | — | — | US | claimed |
| EP-4537908-A1 | COSMETIC COMPOSITION | Taiyo Kagaku Co., Ltd. (JP) | 2025-04-16 | — | — | EP | claimed |
| US-20250115820-A1 | ESTER BASED FUNCTIONAL FLUID | OLEON NV (BE) | 2025-04-10 | — | — | US | claimed |
| EP-4386068-B1 | USE OF AN ESTER BASED FUNCTIONAL FLUID | OLEON NV (BE) | 2025-02-12 | — | — | EP | claimed |
| US-20250009682-A1 | PATCH | KANEKA CORPORATION (JP) | 2025-01-09 | — | — | US | claimed |
| CN-119015394-A | Sulfur-containing compound preparation, and preparation method and application thereof | 上海优斐斯生物科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| WO-2024126732-A1 | ESTER BASED FUNCTIONAL FLUID | OLEON NV (BE) | 2024-06-20 | — | — | WO | claimed |
| EP-4386068-A1 | ESTER BASED FUNCTIONAL FLUID | OLEON NV (BE) | 2024-06-19 | — | — | EP | claimed |
| WO-2023243243-A1 | COSMETIC COMPOSITION | 太陽化学株式会社 | 2023-12-21 | — | — | WO | claimed |
| CN-109419634-B | Oil-in-water emulsion composition and external preparation for skin | 富士胶片株式会社 | 2023-01-31 | — | — | CN | claimed |
| WO-2022220100-A1 | COSMETIC PREPARATION AND FORMULATION USED FOR SAME | 株式会社 資生堂 | 2022-10-20 | — | — | WO | claimed |
| WO-2026105853-A1 | COSMETIC COMPOSITION AND METHOD FOR PRODUCING SAME | 株式会社ダイセル | 2026-05-21 | — | — | WO | disclosed |
| WO-2026105854-A1 | COSMETIC COMPOSITION AND METHOD FOR PRODUCING SAME | 株式会社ダイセル | 2026-05-21 | — | — | WO | disclosed |
| US-12594231-B2 | Emulsified composition and cosmetic material | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-07 | — | — | US | disclosed |
| EP-1914264-B1 | SURFACE-TREATED POWDER AND COSMETIC COMPRISING THE SAME | MIYOSHI KASEI INC (JP) | 2018-08-29 | — | — | EP | disclosed |
| US-8105691-B2 | Hydrophilized surface-treated powder and cosmetics containing same | MIYOSHI KASEI, INC. (JP) | 2012-01-31 | — | — | US | disclosed |
| US-20090263660-A1 | SURFACE-TREATED POWDER AND COSMETICS CONTAINING SAME | MIYOSHI KASEI, INC. (JP) | 2009-10-22 | — | — | US | disclosed |
| EP-1914264-A1 | SURFACE-TREATED POWDER AND COSMETIC COMPRISING THE SAME | Miyoshi Kasei, Inc. (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594231-B2 | Emulsified composition and cosmetic material | LPO, TYR, TAS1R1 | CYP3A4 2732/4885TSHR 132/4885ATM 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.